Chengdu Kanghong Pharmaceutical Group News

Kanghong Pharmaceutical: Announcement on the company\'s participation in the national centralized procurement of drugs to win the bid

Dec 13 11:00 ET

Kanghong Pharmaceutical: Announcement on Cancelling Some Special Fund Raising Accounts

Dec 10 11:00 ET

Kanghong Pharmaceutical: Announcement on the Company\'s receipt of a drug registration certificate

Nov 27 11:00 ET

Kanghong Pharmaceutical: Announcement on the Company\'s receipt of a drug registration certificate

Nov 21 11:00 ET

Kanghong Pharmaceutical: Announcement on the Company\'s receipt of a drug registration certificate

Nov 21 11:00 ET

Kanghong Pharmaceutical: Announcement on the completion of cancellation of some stock options under the 2021 Stock Option Incentive Plan

Oct 29 12:00 ET

Kanghong Pharmaceutical: Announcement on reaching the exercise conditions for the second exercise period of the 2022 Stock Value-added Rights Incentive Plan

Oct 24 12:00 ET

Kanghong Pharmaceutical: Notice on Cancellation of Some Stock Options under the 2021 Stock Option Incentive Plan

Oct 24 12:00 ET

Kanghong Pharmaceutical: Announcement of Supervisory Committee Resolutions

Oct 24 12:00 ET

Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on Cancellation of Part of the Stock Options Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd. in 2021 Stock Option Incentive Plan

Oct 24 12:00 ET

Kanghong Pharmaceutical: Announcement of Board Resolutions

Oct 24 12:00 ET

Kanghong Pharmaceutical: Report for the third quarter of 2024

Oct 24 12:00 ET

Kanghong Pharmaceutical: Legal Opinion of Beijing Commerce (Shenzhen) Law Firm on the Achievement of the Enforcement Conditions for the Second Exercise Period of the 2022 Stock Value-added Rights Incentive Plan of Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Oct 24 12:00 ET

Kanghong Pharmaceutical: Announcement on the Company\'s Receipt of the Drug Clinical Trial Approval Notice

Oct 18 12:00 ET

Kanghong Pharmaceutical: Announcement on Using Own Funds to Purchase Wealth Management Products

Sep 20 12:00 ET

Kanghong Pharmaceutical: Announcement on the resignation of the company\'s senior management

Sep 19 12:00 ET

Kanghong Pharmaceutical: Investor Relations Activity Record Form for September 12, 2024

Sep 12 07:58 ET

Kanghong Pharmaceutical: Announcement on participating in the 2024 Investor Online Group Reception Day and Semi-Annual Report Performance Briefing in the Sichuan Region

Sep 8 23:46 ET

Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan granting autonomous exercise rights for part of the third exercise period for the first time

Sep 3 12:00 ET

Kanghong Pharmaceutical: An indicative announcement on the 2021 Stock Options Incentive Plan to reserve the right to exercise independently during part of the second exercise period

Sep 3 12:00 ET